Gingival enlargement and its risk factors in kidney transplant patients receiving cyclosporine A

Iranian Journal of Kidney Diseases

Volumn 4, Issue 1, 2010, Pages 66-70

  Ghafari, Ali ^a   Poorabbas, Reza ^b   Takieh, James Anvieh ^b   Sepehrvand, Nariman ^a   Kargar, Catauoun ^a   Hatami, Sanaz ^a  

^a URMIA UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cyclosporine; Gingival enlargement; Kidney transplantation

Indexed keywords

AZATHIOPRINE; CAPTOPRIL; CYCLOSPORIN A; DILTIAZEM; ENALAPRIL; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; NIFEDIPINE; PREDNISOLONE;

ADULT; ARTICLE; CONTROLLED STUDY; DRUG BLOOD LEVEL; FEMALE; GINGIVA OVERGROWTH; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; HYPERTRICHOSIS; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; MAJOR CLINICAL STUDY; MALE; TOOTH PLAQUE;

ADULT; CYCLOSPORINE; FEMALE; GINGIVA; GINGIVAL DISEASES; GRAFT REJECTION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; IRAN; KIDNEY TRANSPLANTATION; MALE; MIDDLE AGED; PREVALENCE; RISK FACTORS;

EID: 75649083141     PISSN: 17358582     EISSN: 17358604     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. Carranza FA, Hogan EL. Gingival enlargement. In: Carranza FA, Newman M, Takei H, editors. Clinical periodontology. Philadelphia: WB Saunders; 2002. p. 279-96.
2. Bach JF. Lessons for transplant immunosuppression from the usage of cyclosporine in autoimmune diseases. Transplant Proc. 1994;26:3077-81.
3. Hassell TM. Evidence for production of an inactive collagenase by fibroblasts from phenytoin-enlarged human gingivae. J Oral Pathol. 1982;11:310-7.
4. Seymour RA, Smith DG, Rogers SR. The comparative effects of azathioprine and cyclosporin on some gingival health parameters of renal transplant patients. A longitudinal study. J Clin Periodontol. 1987;14:610-3.
5. Spolidorio LC, Spolidorio DM, Holzhausen M. Effects of long-term cyclosporin therapy on the periodontium of rats. J Periodontal Res. 2004;39:257-62.
6. Mathur H, Moretti AJ, Flaitz CM. Regression of cyclosporia-induced gingival overgrowth upon interruption of drug therapy. Gen Dent. 2003;51:159-62.
7. Seyrafi M, Khaleghjou A, Sadeghi Y. The effect of Cyclosporine A (CsA) on gingival overgrowth in renal allograft recipients. Shahid Beheshti Med Sci Univ J Dent Sch. 1999;17:106-12.
8. Baharvand M, Ranjbar-Pazooki M. Determination of risk factors in Cyclosporine A induced gingival overgrowth. Shahid Beheshti Med Sci Univ J Dent Sch. 2002;20:155-64.
9. Khoori AH, Einollahi B, Ansari G, Moozeh MB. The effect of cyclosporine with and without nifedipine on gingival overgrowth in renal transplant patients. J Can Dent Assoc. 2003;69:236-41.
10. James JA, Marley JJ, Jamal S, et al. The calcium channel blocker used with cyclosporin has an effect on gingival overgrowth. J Clin Periodontol. 2000;27:109-15.
11. Radwan-Oczko M, Boratynska M, Klinger M, Zietek M. Risk factors of gingival overgrowth in kidney transplant recipients treated with cyclosporine A. Ann Transplant. 2003;8:57-62.
12. Allman SD, McWhorter AG, Seale NS. Evaluation of cyclosporin-induced gingival overgrowth in the pediatric transplant patient. Pediatr Dent. 1994;16:36-40.
13. Karpinia KA, Matt M, Fennell RS, Hefti AF. Factors affecting cyclosporine-induced gingival overgrowth in pediatric renal transplant recipients. Pediatr Dent. 1996;18:450-5.
14. Schincaglia GP, Trombelli L, Zangari F, Scabbia A, Griselli A, Calura G. Gingival overgrowth in patients under cyclosporin-A treatment. A clinical study. Minerva Stomatol 1994;43:429-34.
15. Somacarrera ML, Hernández G, Acero J, Moskow BS. Factors related to the incidence and severity of cyclosporin-induced gingival overgrowth in transplant patients. A longitudinal study. J Periodontol. 1994;65:671-5.
16. Thomas DW, Baboolal K, Subramanian N, Newcombe RG. Cyclosporin A-induced gingival overgrowth is unrelated to allograft function in renal transplant recipients. J Clin Periodontol. 2001;28:706-9.
17. Wondimu B, Berg U, Modéer T. Renal function in cyclosporine-treated pediatric renal transplant recipients in relation to gingival overgrowth. Transplantation. 1997;64:92-6.
18. Ilgenli T, Atilla G, Cirit M, Azmak N. The Role of Serum Lipids on Cyclosporine-Induced Gingival Overgrowth in Renal Transplant Patients. Tr J Med Scie. 1999;29:297-301.
19. Hellström MK, Ramberg P, Krok L, Lindhe J. The effect of supragingival plaque control on the subgingival microflora in human periodontitis. J Clin Periodontol. 1996;23:934-40.
20. Thomason JM, Seymour RA, Ellis JS, et al. Determinants of gingival overgrowth severity in organ transplant patients. An examination of the rôle of HLA phenotype. J Clin Periodontol. 1996;23:628-34.
21. Ellis JS, Seymour RA, Taylor JJ, Thomason JM. Prevalence of gingival overgrowth in transplant patients immunosuppressed with tacrolimus. J Clin Periodontol. 2004;31:126-31.
22. James JA, Jamal S, Hull PS, et al. Tacrolimus is not associated with gingival overgrowth in renal transplant patients. J Clin Periodontol. 2001;28:848-52.
23. Margreiter R, Pohanka E, Sparacino V, et al. Open prospective multicenter study of conversion to tacrolimus therapy in renal transplant patients experiencing ciclosporin-related side-effects. Transpl Int. 2005;18:816-23.